Highly accumulated platelet vascular endothelial growth factor in coagulant thrombotic region

Journal of Thrombosis and Haemostasis

Volumn 1, Issue 12, 2003, Pages 2589-2593

  Arisato, T ^a   Hashiguchi, T ^a   Sarker, K P ^a   Arimura, K ^a   Asano, M ^b   Matsuo, K ^b   Osame, M ^b   Maruyama, I ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b Base Technology Center   (Japan)

Author keywords

Coagulation; Platelet; Vascular endothelial growth factor; Wound healing

Indexed keywords

GELATINASE A; VASCULAR ENDOTHELIAL GROWTH FACTOR A, HUMAN; VASCULOTROPIN A;

ARTICLE; BLOOD; BLOOD CLOTTING; BONE MARROW EXAMINATION; CHEMISTRY; CONFOCAL MICROSCOPY; DRUG EFFECT; HUMAN; MEGAKARYOCYTE; PATHOLOGY; PHYSIOLOGY; SECRETION; THROMBOCYTE; THROMBOCYTE AGGREGATION; THROMBOSIS;

BLOOD COAGULATION; BLOOD PLATELETS; BONE MARROW EXAMINATION; HUMANS; MATRIX METALLOPROTEINASE 2; MEGAKARYOCYTES; MICROSCOPY, CONFOCAL; PLATELET AGGREGATION; THROMBOSIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 1542755143     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1046/j.1538-7836.2003.00475.x     Document Type: Article

References (39)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801-9.
2. Czubayko F, Smith RV, Chung HC, Wellstein A. Tumor growth and angiogenesis induced by a secreted binding protein for fibroblast growth factors. J Biol Chem 1994; 269: 28243-8.
3. Lobb RR, Alderman EM, Fett JW. Induction of angiogenesis by bovine brain derived class I heparin-binding growth factor. Biochemistry 1985; 24: 4969-73.
4. Risau WH, Drexler V, Mironov A, Smits A, Siegbahn A, Funa K, Heldin CH. Platelet derived growth factor is angiogenic in vivo. Growth Factors 1992; 7: 261-6.
5. Battegay EJ, Rupp J, Iruela-Arispe L, Sage EH, Pech M. PDGF-BB modulates endothelial proliferation and angiogenesis in vitro via PDGF b-receptors. J Cell Biol 1994; 125: 917-28.
6. Ishikawa F, Miyazono K, Hellman U, Wernstedt C, Haguwara K, Usuki K, Takaku F, Risau W, Heldin CH. Identification of angiogenic activity and the cloning and expressions of platelet-derived endothelial cell growth factor. Nature 1989; 338: 557-62.
7. Schreiber AB, Winkler ME, Derynck R. Transforming growth factor-a: a more potent angiogenic mediator than epidermal growth factor. Science 1986; 232: 1250-3.
8. Roberts AB, Sporn MB, Assoian RK, Smith JM, Roche NS, Wakefield LM, Heine UI, Liotta LA, Falanga V, Kehrl JH, Fauci AS. Transforming growth factor type-b: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA 1986; 83: 4167-71.
9. Frater-Schroder M, Risau W, Hallmann R, Gautschi R, Bohlen P. Tumor necrosis factor type-a, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo. Proc Natl Acad Sci USA 1987; 84: 5277-81.
10. Fett JW, Strydom DJ, Lobb RF, Alderman EM, Bethune JL, Riordan JF, Vallee BL. Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells. Biochemistry 1985; 24: 5480-6.
11. Koch AE, Polverini PJ, Kunkel SL, Harlow LA, DiPietro LA, Elner VM, Elner SG, Strieter RM. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 1992; 258: 1798-801.
12. Ferrara N, Leung DW, Cachianes G, Winer J, Henzel WJ. Purification and cloning of vascular endothelial growth factor secreted by pituitary folliculostellate cells. Methods Enzymol 1991; 198: 391-405.
13. Ferrara N, Houck K, Jakeman L, Leung DW. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocrinol Rev 1992; 13: 18-32.
14. Keck PJ, Hauser SD, Krivi G, Sanzo K, Warren T, Feder J, Connolly DT. Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 1989; 246: 1309-12.
15. Gospodarowicz D, Abraham JA, Schilling J. Isolation and characteriza-tion of a vascular endothelial cell mitogen produced by pituitary-derived folliculostellate cells. Proc Natl Acad Sci USA 1989; 86: 7311-5.
16. Houck KA, Ferrara N, Winer J, Cachianes G, Li B, Leung DW. The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol Endocrinol 1991; 5: 1806-14.
17. Berse B, Brown LF, Van de Water L, Dvorak HF, Senger DR. Vascular permeability factor (vascular endothelial growth factor) gene is ex-pressed differentially in normal tissues, macrophages, and tumors. Mol Biol Cell 1992; 3: 211-20.
18. Monacci WT, Merrill MJ, Oldfield EH. Expression of vascular perme-ability factor/vascular endothelial growth factor in normal rat tissues. Am J Physiol 1993; 264: C995-1002.
19. Tischer E, Mitchell R, Hartman T, Silva M, Gospodarowicz D, Fiddes JC, Abraham A. The human gene for vascular endothelial growth factor. J Biol Chem 1991; 266: 11947-54.
20. Koch AE, Harlow LA, Haines GK, Amento EP, Unemori EN, Wong WL, Pope RM, Ferrara N. Vascular endothelial growth factor. A cytokine modulating endothelial function in rheumatoid arthritis. J Immunol 1994; 152: 4149-56.
21. Möhle R, Green D, Moore MAS, Nachman RL, Rafii S. Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets. Proc Natl Acad Sci USA 1997; 94: 663-8.
22. Banks RE, Forbes MA, Kinsey SE, Stanley A, Ingham E, Walters C, Selby PJ. Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measure-ments and cancer biology. Br J Cancer 1998; 77: 956-64.
23. Hanatani M, Tanaka Y, Kondo S, Ohmori I, Suzuki H. Sensitive chemiluminescence enzyme immunoassay for vascular endothelial growth factor/vascular permeability factor in human serum. Biosci Biotech Biochem 1995; 59: 1958-9.
24. Asano M, Yukita A, Matsumoto T, Hanatani M, Suzuki H. An anti-human VEGF monoclonal antibody, MV833, that exhibits potent anti-tumor activity in vivo. Hybridoma 1998; 17: 185-90.
25. Sawicki G, Salas E, Murat J, Miszta-Lane H, Radomski MW. Release of gelatinase A during platelet activation mediates aggregation. Nature 1997; 386: 616-9.
26. Deuel TF, Huang JS. Platelet-derived growth factor. Structure, function and roles in normal and transformed cells. J Clin Invest 1984; 74: 669-76.
27. Maloney JP, Silliman CC, Ambruso DR, Wang J, Tuder RM, Voelkel NF. In vitro release of vascular endothelial growth factor during platelet aggregation. Am J Physiol 1998; 275: H1054-61.
28. Packham MA, Nishizawa EE, Mustard JF. Response of platelets to tissue injury. Biochem Pharmacol 1968; 17 (Suppl.): 171-84.
29. Nachman RL, Weksler B, Ferris B. Increased vascular permeability produced by human platelet granule cationic extract. J Clin Invest 1970; 49: 274-81.
30. Nachman RL, Weksler B, Ferris B. Characterization of human platelet vascular permeability-enhancing activity. J Clin Invest 1972; 51: 549-56.
31. Miyazono K, Okabe T, Urabe A, Yamanaka M, Takaku F. A platelet factor that stimulates the proliferation of vascular endothelial cells. Biochem Biophys Res Commun 1985; 126: 83-8.
32. Miyazono K, Heldin CH. High yield purification of platelet-derived endothelial cell growth factor: structural characterization and establish-ment of a specific antiserum. Biochemistry 1989; 28: 1704-10.
33. Liotta LA, Tryggvason K, Garbisa S, Hart IR, Foltz CM, Shafie S. Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 1980; 284: 67-8.
34. Fessler LI, Duncan KG, Fessler JH, Salo T, Tryggvason K. Character-isation of the procollagen IV cleavage products produced by a specific tumor collagenase. J Biol Chem 1984; 259: 9783-9.
35. Fini ME, Girard MT. Expression of collagenolytic/gelatinolytic metal-loproteinases by normal cornea. Invest Ophthalmol Vis Sci 1990; 31: 1779-88.
36. Overall CM, Wrana JL, Sodek J. Independent regulation of collagenase, 72kDa progelatinase, and metalloproteinase inhibitor expression in human fibroblasts by transforming growth factor-b. J Biol Chem 1989; 264: 1860-9.
37. Kalebic T, Garbisa S, Glaser B, Liotta LA. Basement membrane collagen: degradation by migrating epithelial cells. Science 1983; 221: 281-3.
38. Garbisa S, Ballin M, Daga-Gordini D, Fastelli G, Naturale M, Negro A, Semenzato G, Liotta LA. Transient expression of type IV collagenolytic metalloproteinase by human mononuclear phagocytes. J Biol Chem 1986; 261: 2369-75.
39. Dvorak HF, Dvorak AM, Manseau EJ, Wiberg L, Churchill WH. Fibrin gel investment associated with line 1 and line 10 solid tumor growth, angiogenesis, and fibroplasia in guinea pigs. Role of cellular immunity, myofibroblasts, microvascular damage, and infarction in line 1 tumor regression. J Natl Cancer Inst 1979; 62: 1459-72.